Current aspects of antiandrogen therapy in women.
Androgenic manifestations in appearance cause not only social and psychological distress for many women, but serious skin, reproductive and metabolic abnormalities as well. Antiandrogen therapy is one of the most promising therapies to treat androgenic disorders. Clinical studies with a variety of agents, including spironolactone, cyproterone acetate, flutamide and finasteride have now proven their utility in the treatment of hirsutism, acne, androgenic alopecia and ovulatory dysfuntion in hyperandrogenic women. Comparative clinical studies, especially with low-dose regimens, suggest that these agents are well tolerated and have the potential for broader clinical utility.
Diamanti-Kandarakis
E
E
Medical School, Athens University, Athens, Greece.
D000726:Androgen Antagonists / Q000627:therapeutic use*; D000728:Androgens / Q000096:biosynthesis* / Q000502:physiology; D002986:Clinical Trials as Topic; D005260:Female; D006727:Hormone Antagonists / Q000627:therapeutic use*; D006801:Humans
D000726:Androgen Antagonists; D000728:Androgens; D006727:Hormone Antagonists